These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32305468)

  • 41. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.
    Holtstiege V; Meier C; Bietenbeck M; Chatzantonis G; Florian A; Köbe J; Reinke F; Eckardt L; Yilmaz A
    J Cardiovasc Magn Reson; 2020 May; 22(1):35. PubMed ID: 32418537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease.
    Yang Y; Connelly KA; Zeidan-Shwiri T; Lu Y; Paul G; Roifman I; Zia MI; Graham JJ; Dick AJ; Crystal E; Wright GA
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):57. PubMed ID: 23803259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up.
    Bernhardt P; Stiller S; Kottmair E; Binner L; Spiess J; Grossmann G; Rasche V; Walcher D; Hombach V
    Int J Cardiovasc Imaging; 2011 Jul; 27(6):893-900. PubMed ID: 20957518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI Assessment of Myocardial Deformation for Risk Stratification of Major Arrhythmic Events in Patients With Non-Ischemic Cardiomyopathy Eligible for Primary Prevention Implantable Cardioverter Defibrillators.
    Ghanbari F; Cirillo J; Rodriguez J; Yue J; Morales MA; Kramer DB; Manning WJ; Nezafat R; Ngo LH
    J Magn Reson Imaging; 2024 Nov; 60(5):1976-1986. PubMed ID: 38240166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.
    Peretto G; Barison A; Forleo C; Di Resta C; Esposito A; Aquaro GD; Scardapane A; Palmisano A; Emdin M; Resta N; Santoni A; Guaricci AI; Santobuono VE; Pepe M; Favale S; Ferrari M; Benedetti S; Della Bella P; Sala S
    Europace; 2020 Dec; 22(12):1864-1872. PubMed ID: 32995851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the ECG based Selvester scoring method to estimate myocardial scar burden and predict clinical outcome in patients with left bundle branch block, with comparison to late gadolinium enhancement CMR imaging.
    Chaudhry U; Platonov PG; Jablonowski R; Couderc JP; Engblom H; Xia X; Wieslander B; Atwater BD; Strauss DG; Van der Pals J; Ugander M; Carlsson M; Borgquist R
    Ann Noninvasive Electrocardiol; 2017 Sep; 22(5):. PubMed ID: 28248005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.
    Olimulder MA; Kraaier K; Galjee MA; Scholten MF; van Es J; Wagenaar LJ; van der Palen J; von Birgelen C
    Int J Cardiovasc Imaging; 2013 Jan; 29(1):169-76. PubMed ID: 22684301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LV Dyssynchrony Is Helpful in Predicting Ventricular Arrhythmia in Ischemic Cardiomyopathy After Cardiac Resynchronization Therapy: A Preliminary Study.
    Tsai SC; Chang YC; Chiang KF; Lin WY; Huang JL; Hung GU; Kao CH; Chen J
    Medicine (Baltimore); 2016 Feb; 95(7):e2840. PubMed ID: 26886645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy.
    Ye Y; Ji Z; Zhou W; Pu C; Li Y; Zhou C; Hu X; Chen C; Sun Y; Huang Q; Zhang W; Qian Y; Ren H; Yu F; Jiang C; Mao Y; Wang B; Augusto JB; Lai D; Hu H; Fu GS
    Front Cardiovasc Med; 2021; 8():758635. PubMed ID: 34869672
    [No Abstract]   [Full Text] [Related]  

  • 52. CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY).
    Krebs J; Mansi T; Delingette H; Lou B; Lima JAC; Tao S; Ciuffo LA; Norgard S; Butcher B; Lee WH; Chamera E; Dickfeld TM; Stillabower M; Marine JE; Weiss RG; Tomaselli GF; Halperin H; Wu KC; Ashikaga H
    Sci Rep; 2021 Nov; 11(1):22683. PubMed ID: 34811411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcomes of patients with ventricular arrhythmias and negative programmed ventricular stimulation followed with implantable loop recorders: Impact of delayed-enhancement cardiac magnetic resonance imaging.
    Gupte T; Liang JJ; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Ghannam M
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2581-2589. PubMed ID: 37921260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
    Chen Z; Sohal M; Voigt T; Sammut E; Tobon-Gomez C; Child N; Jackson T; Shetty A; Bostock J; Cooklin M; O'Neill M; Wright M; Murgatroyd F; Gill J; Carr-White G; Chiribiri A; Schaeffter T; Razavi R; Rinaldi CA
    Heart Rhythm; 2015 Apr; 12(4):792-801. PubMed ID: 25533585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.
    Gutman SJ; Costello BT; Papapostolou S; Voskoboinik A; Iles L; Ja J; Hare JL; Ellims A; Kistler PM; Marwick TH; Taylor AJ
    Eur Heart J; 2019 Feb; 40(6):542-550. PubMed ID: 30107489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incremental value of myocardial viability, evaluated by 18F-fluorodeoxyglucose positron emission tomography, and cardiovascular magnetic resonance for mortality prediction in patients with previous myocardial infarction and symptomatic heart failure.
    Kazakauskaite E; Vajauskas D; Bardauskiene L; Ordiene R; Zabiela V; Zaliaduonyte D; Gustiene O; Lapinskas T; Jurkevicius R
    Perfusion; 2023 Sep; 38(6):1288-1297. PubMed ID: 35503304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arrhythmic Risk Following Recovery of Left Ventricular Ejection Fraction in Patients with Primary Prevention ICD.
    Berthelot-Richer M; Bonenfant F; Clavel MA; Farand P; Philippon F; Ayala-Paredes F; Essadiqi B; Badra-Verdu MG; Roux JF
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):680-9. PubMed ID: 27062583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.